# Jason Gotlib

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jason-gotlib/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,249 |
| Field | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| h-index | 84 |
| i10-index | 271 |
| OpenAlex ID | https://openalex.org/A5065621786 |
| ORCID iD | https://orcid.org/0000-0001-8253-6156 |
| Works | 695 |

## Researcher papers

- [SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis](https://scholariq.org/papers/simplify-1-a-phase-iii-randomized-trial-of-momelotinib-versus-ruxolitinib-in/)
- [Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I](https://scholariq.org/papers/efficacy-safety-and-survival-with-ruxolitinib-in-patients-with-myelofibrosis/)
- [Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/chronic-myeloid-leukemia-version-1-2019-nccn-clinical-practice-guidelines-in/)
- [Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/chronic-myeloid-leukemia-version-2-2021-nccn-clinical-practice-guidelines-in/)
- [A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis](https://scholariq.org/papers/a-pooled-analysis-of-overall-survival-in-comfort-i-and-comfort-ii-2-randomized/)
- [International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study](https://scholariq.org/papers/international-prognostic-scoring-system-for-mastocytosis-ipsm-a-retrospective/)

## Researcher topics

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.